DUBLIN, October 30, 2014 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/spmsvz/process) has announced the addition of the "Process Validation in the US and EU (Workshop, London)" conference to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
Key topics to include:
Benefits In Attending:
Who Should Attend:
This seminar will be of particular interest to all those from the Pharmaceutical Industry working in:
Personnel from the Pharmaceutical and Biopharmaceutical Industry including:
Key Topics Covered:
Day One
09.30 - Welcome and Introduction
10.00 - The Science and Risk Based Approach to Process Validation
10.30 - ICH Q8/9/10/11
11.00 - Coffee
11.20 - Introduction to the FDA Process Validation Guidance
11.50 - Introduction to The EU Process Validation Guideline and Draft Annex 15
12.20 - Discussion
12.30 - Lunch
13.30 - Exercise 1: Guidelines
13.50 - Process Design: FDA Stage 1/ EU Pharmaceutical Development
14.20 - Exercise 2: Process Design
14.50 - Equipment & Utility Qualification: FDA Stage 2.1 / EU Annex 15
15.20 - Tea
15.35 - Exercise 3: Equipment Qualification
16.10 - Feedback and Discussion
16.25 - Process Performance Qualification/ Process Validation: FDA Stage 2.2 / EU approaches
17.00 - End Day One
Day Two
09.00 - Introduction to Day Two
09.15 - Quality Risk Management
09.45 - Exercise 4: Process Validation
10.45 - Coffee
11.05 - Continued Process Verification / Ongoing Process Verification: FDA Stage 3 / EU Annex 15
11.35 - Exercise 5: Ongoing Process Verification
12.05 - Continual Improvement and Process Optimisation
12.30 - Lunch
13.30 - Exercise 6: Continual Improvement
14.30 - Feedback and Discussion
15.00 - Case Study: Process Improvement
15.30 - Tea Break
15.45 - Discussion: Implementation Challenges
16.00 - Case Study: Continued/ Ongoing Process Verification
16.30 - Feedback and Discussion
16.45 - End of Seminar
Speakers
- Bruce Davis is a professional Engineer with 20 years international experience of projects for Drug Substance and Drug Product manufacturing facilities. He was with AstraZeneca where he led major changes to qualification processes globally as well as leading Quality by Design (QbD) cross-functional workshops for new products. He is past ISPE Chairman and Secretary to ASTM E55.03. For ISPE, he led the QbD case study, now published.
- Line Lundsberg, PhD is a Scientist with many years of practical experience from the Pharmaceutical Industry. She works as a consultant and serves several global organisations implementing Quality by Design and Science and Risk based Process Validation. She is one of the co-authors of the ISPE Good Practise Guide: Product Realisation using QbD, Concepts and Principles.
For more information visit http://www.researchandmarkets.com/research/spmsvz/process
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
Share this article